It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Intensive diabetes control has been associated with increased mortality in type 2 diabetes (T2DM); this has been suggested to be due to increased hypoglycemia. We measured hypoglycemia-induced changes in endothelial parameters, oxidative stress markers and inflammation at baseline and after a 24-hour period in type 2 diabetic (T2DM) subjects versus age-matched controls. Case-control study: 10 T2DM and 8 control subjects. Blood glucose was reduced from 5 (90 mg/dl) to hypoglycemic levels of 2.8 mmol/L (50 mg/dl) for 1 hour by incremental hyperinsulinemic clamps using baseline and 24 hour samples. Measures of endothelial parameters, oxidative stress and inflammation at baseline and at 24-hours post hypoglycemia were performed: proteomic (Somalogic) analysis for inflammatory markers complemented by C-reactive protein (hsCRP) measurement, and proteomic markers and urinary isoprostanes for oxidative measures, together with endothelial function. Between baseline and 24 -hours after hypoglycemia, 15 of 140 inflammatory proteins differed in T2DM whilst only 1 of 140 differed in controls; all returned to baseline at 24-hours. However, elevated hsCRP levels were seen at 24-hours in T2DM (2.4 mg/L (1.2–5.4) vs. 3.9 mg/L (1.8–6.1), Baseline vs 24-hours, P < 0.05). In patients with T2DM, between baseline and 24-hour after hypoglycemia, only one of 15 oxidative stress proteins differed and this was not seen in controls. An increase (P = 0.016) from baseline (73.4 ng/mL) to 24 hours after hypoglycemia (91.7 ng/mL) was seen for urinary isoprostanes. Hypoglycemia resulted in inflammatory and oxidative stress markers being elevated in T2DM subjects but not controls 24-hours after the event.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull, UK (GRID:grid.413631.2) (ISNI:0000 0000 9468 0801); Centre for Cardiovascular and Metabolic Research, Hull York Medical School, Hull, UK (GRID:grid.413631.2) (ISNI:0000 0000 9468 0801)
2 Weill Cornell Medicine Qatar, Education City, PO, Doha, Qatar (GRID:grid.413631.2)
3 Centre for Cardiovascular and Metabolic Research, Hull York Medical School, Hull, UK (GRID:grid.413631.2) (ISNI:0000 0000 9468 0801)
4 Diabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), PO Box, Doha, Qatar (GRID:grid.418818.c) (ISNI:0000 0001 0516 2170)
5 Proteomics Core, Weill Cornell Medicine-Qatar, Education City, PO Box, Doha, Qatar (GRID:grid.418818.c); Scientific Service Group Biomolecular Mass Spectrometry, Max Planck Institute for Heart and Lung Research, Ludwigstr. 43, Bad Nauheim, Germany (GRID:grid.418032.c) (ISNI:0000 0004 0491 220X)
6 Proteomics Core, Weill Cornell Medicine-Qatar, Education City, PO Box, Doha, Qatar (GRID:grid.418032.c)
7 Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull, UK (GRID:grid.413631.2) (ISNI:0000 0000 9468 0801)
8 Royal College of Surgeon in Ireland, Manama, Bahrain (GRID:grid.413631.2)